Search results
- Partnering with Blackford provides healthcare organizations access to a wide portfolio of AI solutions via a single tried-and-tested platform. The collaboration with Bayer has its roots in 2019, when Blackford was among the selected start-ups of Bayer’s G4A Digital Health Partnerships Program that year.
People also ask
How did Blackford & Bayer collaborate?
Why is Blackford partnering with Bayer?
Does Bayer own Blackford?
Who owns Blackford analysis?
Who is Blackford analysis?
How does Blackford benefit from Bayer?
Jan 18, 2023 · Partnering with Blackford provides healthcare organizations access to a wide portfolio of AI solutions via a single tried-and-tested platform. The collaboration with Bayer has its roots in 2019, when Blackford was among the selected start-ups of Bayer’s G4A Digital Health Partnerships Program that year. About Bayer
- Bayer and Blackford Analysis to Collaborate on Integration of ...
The digital platform by Bayer and Blackford Analysis will...
- Bayer completes acquisition of Blackford Analysis Ltd.
The acquisition of Blackford bolsters Bayer’s position in...
- Bayer and Blackford Analysis to Collaborate on Integration of ...
Feb 13, 2023 · The acquisition of Blackford bolsters Bayer’s position in digital medical imaging and follows a development and license agreement between both companies in 2020 that laid the foundation for Bayer’s recently launched medical imaging platform, Calantic™ Digital Solutions.
Dec 1, 2020 · The digital platform by Bayer and Blackford Analysis will provide access to a growing number of diagnostic imaging analysis applications, protocol management tools, departmental workflow tools and AI algorithms.
Feb 13, 2023 · The acquisition of Blackford bolsters Bayer’s position in digital medical imaging and follows a development and license agreement between both companies in 2020 that laid the foundation for Bayer’s recently launched medical imaging platform, Calantic™ Digital Solutions.
Blackford Analysis, a leading strategic imaging Artificial Intelligence (AI) platform and solutions provider and University of Edinburgh spinout, has announced its acquisition by Bayer, a global life science company.
Jan 18, 2023 · The acquisition follows a collaboration between both companies that laid the foundation for Bayer’s recently launched Calantic medical imaging AI platform. Our team’s expertise and success to date were important factors in Bayer’s acquisition, bolstering its position in the imaging AI space.
Jan 18, 2023 · Partnering with Blackford provides healthcare organizations access to a wide portfolio of AI solutions via a single tried-and-tested platform. The collaboration with Bayer has its roots in...
